Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Legal Guidelines for Documentation01:06

Legal Guidelines for Documentation

2.4K
The legal guidelines for nursing documentation are essential for ensuring accurate, professional, and ethical recording of patient care. The guidelines are discussed here:
2.4K
Ethical Standards I01:25

Ethical Standards I

1.5K
The American Nurses Association (ANA) created and implemented the first nationally accepted Code of Ethics for Nurses with Interpretive Statements. The Code of Ethics is a living document regularly updated by the ANA and establishes an ethical standard that is non-negotiable for nurses in all roles and settings.
The Code of Ethics provisions outline the nurse's duty to the patient, the healthcare team, the profession, and society. The Code's fundamental principles include advocacy,...
1.5K
Ethical Standards II01:23

Ethical Standards II

1.2K
Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
1.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reframing AI for Rare Disease Recognition.

Research square·2026
Same author

Translating AI research into reality: summary of the 2025 voice AI Symposium and Hackathon.

Frontiers in digital health·2026
Same author

The need to develop health data transaction disclosure requirements to balance transparency, privacy, and progressive use.

The Lancet. Digital health·2026
Same author

Scale-up Unlearnable Examples Learning with High-Performance Computing.

IS&T International Symposium on Electronic Imaging·2025
Same author

A consensus privacy metrics framework for synthetic data.

Patterns (New York, N.Y.)·2025
Same author

Re-identification risk for common privacy preserving patient matching strategies when shared with de-identified demographics.

Journal of the American Medical Informatics Association : JAMIA·2025
Same journal

Real-time EEG-based epileptic seizure prediction using artificial intelligence: A systematic review.

Artificial intelligence in medicine·2026
Same journal

R-peak detection and ECG data compression scheme based on empirical mode decomposition and wavelet transform.

Artificial intelligence in medicine·2026
Same journal

CastNet: A three-channel EEG-based deep learning model for cross-subject depression detection.

Artificial intelligence in medicine·2026
Same journal

State-of-the-art TinyML approaches for colorectal cancer detection: Current advances, challenges, and future directions.

Artificial intelligence in medicine·2026
Same journal

JRadiEvo: A Japanese radiology report generation model enhanced by evolutionary optimization of model merging.

Artificial intelligence in medicine·2026
Same journal

Causally-informed deep learning towards explainable and generalizable outcome prediction in critical care.

Artificial intelligence in medicine·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Combining Augmented Reality and 3D Printing to Display Patient Models on a Smartphone
09:26

Combining Augmented Reality and 3D Printing to Display Patient Models on a Smartphone

Published on: January 2, 2020

19.4K

A computational model to protect patient data from location-based re-identification.

Bradley Malin1

  • 1Department of Biomedical Informatics, Eskind Biomedical Library, Fourth Floor, 2209 Garland Avenue, Vanderbilt University, Nashville, TN 37232-8340, USA. b.malin@vanderbilt.edu

Artificial Intelligence in Medicine
|June 5, 2007
PubMed
Summary
This summary is machine-generated.

Protecting patient DNA data from re-identification is crucial. New computational methods ensure patient anonymity in shared databases by preventing "trail re-identification" of DNA records, allowing for greater data disclosure.

More Related Videos

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
06:32

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

2.1K
Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions
06:18

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions

Published on: April 5, 2024

1.9K

Related Experiment Videos

Last Updated: May 4, 2026

Combining Augmented Reality and 3D Printing to Display Patient Models on a Smartphone
09:26

Combining Augmented Reality and 3D Printing to Display Patient Models on a Smartphone

Published on: January 2, 2020

19.4K
Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring
06:32

Author Spotlight: Automated Deep Brain Stimulation for Parkinson's Disease - Exploring the Possibilities and Challenges of Home Monitoring

Published on: July 14, 2023

2.1K
Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions
06:18

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions

Published on: April 5, 2024

1.9K

Area of Science:

  • Health Informatics
  • Bioinformatics
  • Data Privacy

Background:

  • Healthcare organizations must protect patient anonymity when disclosing sensitive data like DNA.
  • Traditional de-identification methods are vulnerable to re-identification using public information.
  • Patient location visit patterns ('trails') pose a threat to DNA data anonymity when disclosed by multiple organizations.

Purpose of the Study:

  • To develop computational methods for disclosing patient-specific DNA records that are resistant to trail re-identification.
  • To provide health care organizations with solutions to prevent patient anonymity threats in shared databases.
  • To enable the disclosure of DNA records while ensuring provable protection against re-identification.

Main Methods:

  • Introduced a formal model called k-unlinkability to define degrees of patient anonymity.
  • Developed algorithms for coordinating data disclosure among health care organizations to maintain k-unlinkability.
  • Evaluated algorithm efficacy using patient population data from hospital discharge databases and real-world metrics.

Main Results:

  • It is not necessary to suppress all records violating k-unlinkability; only portions of trails require suppression.
  • Applying protection algorithms significantly increases the percentage of disclosable DNA records while maintaining k-unlinkability (e.g., 95% disclosure achieved).
  • Experimental findings demonstrate the effectiveness of the proposed methods across various patient populations.

Conclusions:

  • Patient anonymity can be formally protected in shared healthcare databases.
  • Significant quantities of patient-specific DNA data can be disclosed with guaranteed protection against trail re-identification.
  • The developed methods offer configurable privacy protection levels, enabling informed policy formulation.